Experiments on antagonism of barbiturate anesthesia with adrenergic, serotonergic, and cholinergic stimulants given alone and in combination.
D000661:Amphetamine / Q000008:administration & dosage / Q000494:pharmacology*; D000771:Anesthesia, Intravenous / Q000662:veterinary*; D000818:Animals; D001463:Barbiturates / Q000037:antagonists & inhibitors*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002417:Cattle; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D010095:Oxotremorine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology*; D011229:Preanesthetic Medication; D011941:Receptors, Adrenergic / Q000187:drug effects; D011950:Receptors, Cholinergic / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012701:Serotonin / Q000097:blood; D013566:Sympathomimetics / Q000494:pharmacology*; D013569:Synapses / Q000187:drug effects; D013997:Time Factors; D015016:Yohimbine / Q000008:administration & dosage / Q000494:pharmacology*
D001463:Barbiturates; D010277:Parasympathomimetics; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D013566:Sympathomimetics; D015016:Yohimbine; D012701:Serotonin; D010095:Oxotremorine; D010830:Physostigmine; D000661:Amphetamine